Penserra Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,640
Closed -$485K 1302
2023
Q3
$485K Buy
+6,640
New +$449K 0.01% 518
2022
Q4
Sell
-12,258
Closed -$823K 1180
2022
Q3
$823K Sell
12,258
-3,592
-23% -$227K 0.02% 382
2022
Q2
$973K Buy
+15,850
New +$1.02M 0.03% 390
2018
Q4
Sell
-180,074
Closed -$17M 696
2018
Q3
$17M Buy
180,074
+7,035
+4% +$606K 1.04% 36
2018
Q2
$13M Buy
173,039
+63,749
+58% +$4.58M 0.82% 44
2018
Q1
$6.62M Buy
+109,290
New +$5.92M 0.63% 57
2017
Q1
Sell
-17,940
Closed -$726K 686
2016
Q4
$726K Buy
+17,940
New +$693K 0.08% 108

Other funds holding HQY

Penserra Capital Management's HQY Position: Q4 2023 in Review

Penserra Capital Management sold out of HealthEquity (HQY) in Q4 2023, closing a stake of 6,640 shares — an estimated $485K sold.

Penserra Capital Management first reported a position in HQY in Q4 2016 and held it in 7 quarters. The position peaked at $17M in Q3 2018. 352 funds tracked by Wall St. Rank hold HQY as of Q4 2023.

  • Penserra Capital Management reported no remaining HealthEquity position as of Q4 2023 after selling out during the quarter.
  • Penserra Capital Management sold 6,640 HealthEquity shares in Q4 2023, an estimated $485K.
  • Penserra Capital Management first reported a position in HealthEquity in Q4 2016 and held it in 7 quarters.
  • Penserra Capital Management's HealthEquity position peaked at $17M in Q3 2018.
  • 352 funds tracked by Wall St. Rank held HealthEquity as of Q4 2023.

Based on Penserra Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.